Literature DB >> 7016245

Deep venous thrombosis after total hip arthroplasty: a prospective controlled study to determine the prophylactic effect of graded pressure stockings.

M A Ishak, K D Morley.   

Abstract

Graded pressure stockings significantly reduced the incidence of venographically determined deep venous thrombosis (DVT) after total hip arthroplasty. Seventy-six patients were studied; the incidence of DVT was 54 per cent in 41 control patients and 20 per cent in 35 patients who wore stockings. Administration of blood during the operation and in the first 24 h after operation, if given in excess of blood loss, was associated with a significantly increased risk of developing DVT. The application of graded pressure stockings and the avoidance of unnecessary perioperative blood transfusion are worth while in the management of total hip arthroplasty.

Entities:  

Mesh:

Year:  1981        PMID: 7016245     DOI: 10.1002/bjs.1800680622

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

Review 1.  The venous footpump: influence on tissue perfusion and prevention of venous thrombosis.

Authors:  A M Gardner; R H Fox
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

Review 2.  Surgical treatment of the rheumatoid hip.

Authors:  I G Kelly
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

3.  [Principles of physical prevention of thrombosis].

Authors:  W Theiss; S Haas
Journal:  Langenbecks Arch Chir       Date:  1986

Review 4.  Prevention and treatment of venous thromboembolism.

Authors:  G F Pineo; R D Hull
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

Review 5.  Thigh length versus knee length antiembolism stockings for the prevention of deep vein thrombosis in postoperative surgical patients; a systematic review and network meta-analysis.

Authors:  Ros Wade; Fiona Paton; Stephen Rice; Gerard Stansby; Peter Millner; Hayley Flavell; Dave Fox; Nerys Woolacott
Journal:  BMJ Open       Date:  2016-02-16       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.